Watch Demo

Switzerland Anti-Infective Industry Outlook 2022 - 2026

See how Switzerland Anti-Infective performed compared to key markets such as the United Kingdom, Germany and South Korea.

Key Market Indicators

Sales of Swiss antiinfective medicines are expected to reach $645 million by 2026, up from $598 million in 2021. This averages out to an annual growth rate of 1.4%. Since 1993, Swiss market growth has been 1.5% year on year. In 2021, Switzerland placed 13th in the rankings, with Chile coming slightly ahead at $597 million. Germany, South Korea and Italy ranked second, third and fourth, respectively. Swiss imports of antibiotics are projected to reach $316 million in 2026, down from $356 million in 2021. This works out to an average decline of 1.6% year on year. Since 1993, demand for antibiotics in Switzerland has increased by 2% year on year. Meanwhile, exports of Swiss antibiotics are set to reach $1.91 billion in 2026, up from $1.79 billion in 2021. This averages out to a growth rate of 1.3% year on year. Since 1993, Swiss supply has grown 6.4% year on year. Switzerland placed second in 2021, with China overtaking at $1.79 billion. Italy and India ranked third and fourth, respectively.

Marketing Banner

Switzerland Anti-Infective Market Data and Forecasts

How much will Switzerland Anti-Infective Market grow to 2026?

Forecast: Antiinfective Medicine Sales in Switzerland
Forecast: Antiinfective Medicine Sales in Switzerland
Forecast: Antiinfective Medicine Sales in Switzerland
More in Anti-Infective Industry for 2028

Improve your Knowledge with the latest Indicators and Trends